Multiple sclerosis treatment options have expanded dramatically over the past several years. In addition to subcutaneous and intravenous medications, there are now 3 disease-modifying oral therapies available in the United States.
Stacey Ness, PharmD, RPh, MSCS, AAHIVP
Advertisement
Articles by Stacey Ness, PharmD, RPh, MSCS, AAHIVP
Advertisement
Latest Updated Articles
Specialty Pharmacy Considerations for Oral Multiple Sclerosis TherapiesPublished: October 9th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA, HHS Move to Accelerate Biosimilar Approvals
2
Accelerated Approval of Cancer Drugs: Benefit or Burden?
3
COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer
4
Pharmacists Lead the Way in Evolving CAR T-Cell and Bispecific Antibody Therapy Management
5
